Human papillomavirus (HPV) vaccines

Routine vaccination:
    • Minimum age: 9 years
    • HPV4 [Gardasil®] and HPV2 [Cervarix®] are licensed and available.
    • Only 2 doses of either of the two HPV vaccines (HPV4 & HPV2) for adolescent/preadolescent girls aged 9-14 years;
    • For girls 15 years and older, and immunocompromised individuals 3 doses are recommended
    • For two-dose schedule, the minimum interval between doses should be 6 months.
    • Either HPV4 (0, 2, 6 months) or HPV2 (0, 1, 6 months) is recommended in a 3-dose series for females aged 15 years and older
    • HPV4 can also be given in a 3-dose series for males aged 11 or 12 years, but not yet licensed for use in males in India.
    • The vaccine series can be started beginning at age 9 years.
    • For three-dose schedule, administer the 2nd dose 1 to 2 months after the 1st dose and the 3rd dose 6 months after the 1st dose (at least 24 weeks after the first dose).

    Catch-up vaccination:
    • Administer the vaccine series to females (either HPV2 or HPV4) at age 13 through 45 years if not previously vaccinated.
    • Use recommended routine dosing intervals (see above) for vaccine series catch-up.